Results 161 to 170 of about 135,370 (254)
Analysis of Research Trends and Output Effectiveness in the Medical Field Based on the National Natural Science Foundation of China. [PDF]
Jin H, Hui H, Xinjie B, Hua B.
europepmc +1 more source
Inhibition of KDELR2 in a small fraction of tumor cells generates sustainable immunogenic cell death conditions within the tumor microenvironment. These conditions promote the regression of tumors in a T cell independent manner. During regression, macrophages prime T cells that subsequently provide systemic protection against recurrence. The potency of
Shakti P Pattanayak +6 more
wiley +1 more source
Autochthonous Neurocysticercosis Brain Lesions Mimicking Metastatic Disease, Spain. [PDF]
Hernández-Sánchez E +3 more
europepmc +1 more source
CHCHD10 loss in Alzheimer's disease is associated with mitochondrial dysfunction, epigenomic disruption, and tau pathology. Restoration of CHCHD10 shifts DNA methylation toward a non‐disease state and reduces tau and amyloid pathology, with KATNAL2 acting as a downstream effector.
Teresa M. Thomas +13 more
wiley +1 more source
The "Asian Paradox" in multiple primary lung cancer: a geographic monopole driven by phenotypic divergence. [PDF]
Shi J, Gao Y.
europepmc +1 more source
ABSTRACT Glioblastoma multiforme (GBM) remains largely incurable due to the blood‐brain barrier (BBB) and immunosuppressive microenvironment. While boron neutron capture therapy (BNCT) selectively eradicates tumor cells via 10B(n, α)‐7Li reactions, its clinical potential in GBM is unrealized because of the suboptimal pharmacokinetics of conventional ...
Jiawen Chen +22 more
wiley +1 more source
AhR-Siglec-15 axis regulates lysosomal Ca2+ release for sonic hedgehog medulloblastoma growth via TRPML1. [PDF]
Wang Z +13 more
europepmc +1 more source
UBE2O targets CDKL1 for the degradation to upregulate PD‐L1 expression and promotes resistance to radioimmunotherapy in lung cancer, supporting the potential of targeting UBE2O as a promising therapeutic strategy. ABSTRACT Resistance to radioimmunotherapy is one of the primary causes of treatment failure in lung cancer patients; however, the underlying
Huichan Xue +6 more
wiley +1 more source
Non-union after bisphosphonate-associated atypical femoral fractures: a review of the current literature. [PDF]
Dowling J, Marsh S, O'Grady J.
europepmc +1 more source

